These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8895659)

  • 21. High specificity of Müllerian-inhibiting substance signaling in vivo.
    Mishina Y; Whitworth DJ; Racine C; Behringer RR
    Endocrinology; 1999 May; 140(5):2084-8. PubMed ID: 10218958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
    Park JH; Tanaka Y; Arango NA; Zhang L; Benedict LA; Roh MI; Donahoe PK; Teixeira JM
    Dev Biol; 2014 Feb; 386(1):227-36. PubMed ID: 24362065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overactivation of hedgehog signaling in the developing Müllerian duct interferes with duct regression in males and causes subfertility.
    Migone FF; Hung PH; Cowan RG; Selvaraj V; Suarez SS; Quirk SM
    Reproduction; 2017 Apr; 153(4):481-492. PubMed ID: 28123059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.
    Baarends WM; van Helmond MJ; Post M; van der Schoot PJ; Hoogerbrugge JW; de Winter JP; Uilenbroek JT; Karels B; Wilming LG; Meijers JH
    Development; 1994 Jan; 120(1):189-97. PubMed ID: 8119126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mullerian inhibiting substance is required for germ cell proliferation during early gonadal differentiation in medaka (Oryzias latipes).
    Shiraishi E; Yoshinaga N; Miura T; Yokoi H; Wakamatsu Y; Abe S; Kitano T
    Endocrinology; 2008 Apr; 149(4):1813-9. PubMed ID: 18162517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paracrine-mediated apoptosis in reproductive tract development.
    Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
    Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
    Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
    Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intersex, Hermaphroditism, and Gonadal Plasticity in Vertebrates: Evolution of the Müllerian Duct and Amh/Amhr2 Signaling.
    Adolfi MC; Nakajima RT; Nóbrega RH; Schartl M
    Annu Rev Anim Biosci; 2019 Feb; 7():149-172. PubMed ID: 30303691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YWK-II protein as a novel G(o)-coupled receptor for Müllerian inhibiting substance in cell survival.
    Yin X; Ouyang S; Xu W; Zhang X; Fok KL; Wong HY; Zhang J; Qiu X; Miao S; Chan HC; Wang L
    J Cell Sci; 2007 May; 120(Pt 9):1521-8. PubMed ID: 17452623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental expression of a candidate müllerian inhibiting substance type II receptor.
    Teixeira J; He WW; Shah PC; Morikawa N; Lee MM; Catlin EA; Hudson PL; Wing J; Maclaughlin DT; Donahoe PK
    Endocrinology; 1996 Jan; 137(1):160-5. PubMed ID: 8536608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
    Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
    Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mullerian-inhibiting substance deficiency in transgenic mice interferes with postnatal germ cell development: clues for understanding infertility in cryptorchidism.
    Prasetyo R; Farmer P; McLennan I; Southwell B; Hutson J
    J Pediatr Surg; 2009 Dec; 44(12):2335-8. PubMed ID: 20006021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Müllerian inhibitory substance induces growth of rat preantral ovarian follicles.
    McGee EA; Smith R; Spears N; Nachtigal MW; Ingraham H; Hsueh AJ
    Biol Reprod; 2001 Jan; 64(1):293-8. PubMed ID: 11133686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.
    Renaud EJ; MacLaughlin DT; Oliva E; Rueda BR; Donahoe PK
    Proc Natl Acad Sci U S A; 2005 Jan; 102(1):111-6. PubMed ID: 15618407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Müllerian inhibiting substance in sex-reversed dogs.
    Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
    Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
    Wu X; Arumugam R; Baker SP; Lee MM
    Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
    Burns KH; Agno JE; Sicinski P; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.